TipRanks
Go Ultimate55% OFF

Michael Baker Insider Profile

4 Followers

Michael Baker, Chief Executive Officer & Managing Director at Percheron Therapeutics, holds 20.00M shares in Percheron Therapeutics (Ticker: PERCF), holds 8.18M shares in Arovella Therapeutics Limited (Ticker: AU:ALA). Most recently, Michael Baker Bought ― shares of Percheron Therapeutics on Oct 15, 2026 for an estimated value of $100.00K.

Michael Baker's Trading History

PERCF
Percheron Therapeutics
Oct 15, 2026Chief Executive Officer & Managing DirectorInformative Buy100.00K$200.00K
ALA
Arovella Therapeutics Limited
Oct 15, 2025Chief Executive Officer & Managing DirectorUninformative Sell―AU$433.78K

You May Also Like

Michael Baker insider profile FAQ

What is the percentage of profitable transactions made by Michael Baker?
The percentage of profitable transactions made by Michael Baker is 43%.
What is the average return per transaction made by Michael Baker?
The average return per transaction made by Michael Baker is 29.20%.
What stocks does Michael Baker hold?
Michael Baker holds: PERCF, AU:ALA stocks.
What was Michael Baker’s latest transaction?
Michael Baker’s latest transaction was an Informative Buy of $100.00K.
What was Michael Baker's most profitable transaction?
Michael Baker’s most profitable transaction was an Informative Buy of AU:ALA stock on July 12, 2023. The return on the trade was 216.60%.
What is Michael Baker's role in Percheron Therapeutics?
Michael Baker's role in Percheron Therapeutics is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.